Methylenetetrahydrofolate reductase inhibitors and use thereof
CA 2429583 A1 · Owner: Sekhon, Jaspreet · Inventors: Rozen, Rima; Sekhon, Jaspreet
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methylenetetrahydrofolate reductase (MTHFR) inhibitors for use in selective inhibition of cancer cell growth in a mammal. These inhibitors can be a small molecule an antisense oligonucleotide, a , ribozyme a triple helix forming oligonucleotide an anti-MTHFR antibody or , fragment thereof an MTHFR mutant or a fragment of MTHFR. The present invention further provides nucleic acids encoding an inhibitor of MTHFR and , vectors comprising these nucleic acids. Also encompassed by the present invention are methods of using the MTHFR inhibitors for selective inhibition of cancer cell growth, and pharmaceutical compositions comprising the MTHFR inhibitors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 3, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 3, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 3, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.